Figure 5

Tumor somatic gene mutation and immunotherapy response prediction. (A) Mutation landscape of tumor somatic cells in patients with cluster C1. (B) Landscape of tumor somatic cell mutations in patients with C2 clusters. (C) Differences in the distribution of tumor mutation burden among clusters. (D–F) Differences between different clusters in TCR Richness (D), BCR Richness (E) and CTA scores (F).